Review of Anti-Hyperglycemic Effect of Tinospora crispa

Authors

  • Theerawut KLANGJAREONCHAI Department of Medicine, Ramathibodi Hospital, Faculty of Medicine, Mahidol University, Bangkok 10400
  • Supanee PUTADECHAKUM Research Center, Ramathibodi Hospital, Faculty of Medicine, Mahidol University, Bangkok 10400
  • Chulaporn ROONGPISUTHIPONG Department of Medicine, Ramathibodi Hospital, Faculty of Medicine, Mahidol University, Bangkok 10400

Keywords:

Tinospora crispa, borapet, borapetoside C, diabetes mellitus, anti-hyperglycemic effect

Abstract

Tinospora crispa (Borapet or Wan kab hoi yai) is a climbing plant belonging to family Menispermaceae. In traditional medicine, an extract from the stems of T. crispa has been used for anti-hyperglycemic activity. The mechanisms of the anti-hyperglycemic actions of T. crispa are due to the stimulation of insulin secretion, enhancement of glucose utilization in peripheral tissues and reduction of hepatic gluconeogenesis. Borapetoside A and C are active ingredients for lower plasma glucose. In human studies, T. crispa extract possesses a significant anti-hyperglycemic effect in metabolic syndrome but this effect is abolished in type 2 diabetes mellitus. More clinical studies are recommended to evaluate the beneficial effect of T. crispa in human models.

doi:10.14456/WJST.2015.88

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

References

W Aekplakorn, RP Stolk, B Neal, P Suriyawongpaisal, V Chongsuvivatwong, S Cheepudomwit and M Woodward. The prevalence and management of diabetes in Thai adults: The international collaborative study of cardiovascular disease in Asia. Diabetes Care 2003; 26, 2758-63.

F Fumeron, AF Reis and G Velho. Genetics of macrovascular complications in diabetes. Curr. Diab. Rep. 2006; 6, 162-8.

SS Rich. Genetics of diabetes and its complications. J. Am. Soc. Nephrol. 2006; 17, 353-60.

AB Olokoba, OA Obateru and LB Olokoba. Type 2 diabetes mellitus: a review of current trends. Oman. Med. J. 2012; 27, 269-73.

N Kongkathip, P Dhumma-upakorn, B Kongkathip, K Chawananoraset, P Sangchomkaeo and S Hatthakitpanichakul. Study on cardiac contractility of cycloeucalenol and cycloeucalenone isolated from Tinospora crispa. J. Ethnopharmacol. 2002; 83, 95-9.

H Higashino, A Suzuki, Y Tanaka and K Pootakham. Inhibitory effects of Siamese Tinospora crispa extracts on the carrageenin-induced foot pad edema in rats (the 1st report). Nihon. Yakurigaku. Zasshi. 1992; 100, 339-44.

T Rungruang and T Boonmars. In vivo antiparasitic activity of the Thai traditional medicine plant-Tinospora crispa-against Plasmodium yoelii. Southeast Asian J. Trop. Med. Public Health 2009; 40, 898-900.

H Noor and SJ Ashcroft. Pharmacological characterisation of the antihyperglycaemic properties of Tinospora crispa extract. J. Ethnopharmacol. 1998; 6, 7-13.

CT Ruan, SH Lam, TC Chi, SS Lee and MJ Su. Borapetoside C from Tinospora crispa improves insulin sensitivity in diabetic mice. Phytomedicine 2012; 19, 719-24.

H Noor and SJ Ashcroft. Antidiabetic effects of Tinospora crispa in rats. J. Ethnopharmacol. 1989; 27, 149-61.

H Noor, P Hammonds, R Sutton and SJ Ashcroft. The hypoglycaemic and insulinotropic activity of Tinospora crispa: Studies with human and rat islets and HIT-T15 B cells. Diabetologia 1989; 32, 354-59.

K Noipha, J Purintrapiban, A Herunsalee and S Ratanachaiyavong. In vitro glucose uptake activity of Tinospora crispa in skeletal muscle cells. Asian Biomedicine 2008; 2, 415-20.

SH Lam, CT Ruan, PH Hsieh, MJ Su and SS Lee. Hypoglycemic diterpenoids from Tinospora crispa. J. Nat. Prod. 2012; 75, 153-9.

CT Ruan, SH Lam, SS Lee and MJ Su. Hypoglycemic action of borapetoside A from the plant Tinospora crispa in mice. Phytomedicine 2013; 20, 667-75.

C Sangsuwan, S Udompanthurak, S Vannasaeng and V Thamlikitkul. Randomized controlled trial of Tinospora crispa for additional therapy in patients with type 2 diabetes mellitus. J. Med. Assoc. Thai 2004; 87, 543-6.

T Klangjareonchai and C Roongpisuthipong. The effect of Tinospora crispa on serum glucose and insulin levels in patients with type 2 diabetes mellitus. J. Biomed. Biotechnol. 2012; 2012, 808762.

C Sriyapai, R Dhumma-upakorn, S Sangwatanaroj, N Kongkathip and S Krittiyanunt. Hypoglycemic effect of Tinospora crispa dry powder in outpatients with metabolic syndrome at king chulalongkorn memorial hospital. J. Health Res. 2009; 23, 125-33.

F Stickel, E Patsenker and D Schuppan. Herbal hepatotoxicity. J. Hepatol. 2005; 43, 901-10.

PJ Neuvonen, M Niemi and JT Backman. Drug interactions with lipid-lowering drugs: Mechanism and clinical relevance. Clin. Pharmacol. Ther. 2006; 80, 565-81.

P Chavalittumrong, A Attawish, A Chuthaputti and P Chuntapet. Toxicological study of crude extract of Tinospora crispa Mier ex Hook F. & Thoms. Thai J. Pharm. Sci. 1997; 21, 199-210.

Downloads

Published

2015-01-16

How to Cite

KLANGJAREONCHAI, T., PUTADECHAKUM, S., & ROONGPISUTHIPONG, C. (2015). Review of Anti-Hyperglycemic Effect of Tinospora crispa. Walailak Journal of Science and Technology (WJST), 12(5), 403–406. Retrieved from https://wjst.wu.ac.th/index.php/wjst/article/view/551